Cryopreservation startup Acorn Biolabs seeded with $3.3 mln

Toronto-based biotechnology startup Acorn Biolabs has raised $3.3 million in a seed-stage financing. The round was backed by Canadian investors Real Ventures, Globalive Technology, Pool Global Partners and Epic Capital Management, among others. Founded in 2017 by CEO Drew Taylor, CSO Patrick Pumputis and CTO Steven ten Holder, Acorn has developed a home-based, non-invasive solution that allows consumers to collect and preserve live cells for future therapeutic uses. The company, located in MaRS Discovery District's JLABS, will use the funds raised to add to its team and prepare for the technology's commercial launch in Q2 2019.